×

Global Next Generation Cancer Diagnostic Devices Market Report: 2013 Edition

Research and Markets logo

Dublin, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/dn5vq5/global_next) has announced the addition of the "Global Next Generation Cancer Diagnostic Devices Market 2012-2016" report to their offering.

The key vendors dominating this space are Roche Holding Ltd., Abbott Laboratories, Siemens Healthcare, and Agilent Technologies Inc.

Global Next-generation Cancer Diagnostic Devices market to grow at a CAGR of 48.11 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Next-generation Cancer Diagnostic Devices market has also been witnessing an increase in mergers and acquisitions among vendors. However, intense competition among vendors could pose a challenge to the growth of this market.

Global Next-generation Cancer Diagnostic Devices Market 2012-2016 covers the Global Next-generation Cancer Diagnostic Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key questions answered in this report:

  • What will the market size be in 2016 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

Key Topics Covered:

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

05. Geographical Segmentation

06. Vendor Landscape

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis

  • A. Menarini Diagnostics S.r.l.
  • AVIVA Biosciences Corp.
  • Abbott Laboratories
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Allegro Diagnostics Corp.
  • Asuragen Inc.
  • Becton Dickinson and Co.
  • Cepheid Inc.
  • Fluidigm Corp.
  • Fujirebio Diagnostics Inc.
  • GE Healthcare
  • Illumina Inc.
  • Johnson & Johnson
  • Life Technologies Corp.
  • Luminex Corp.
  • Nanosphere Inc.
  • Oncolys BioPharma Inc.
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Radient Pharmaceuticals Corp.
  • Randox Laboratories Ltd.
  • Roche Holding Ltd.
  • Siemens Healthcare
  • SomaLogic Inc.
  • Thermo Fisher Scientific Inc.
  • Veridex LLC
  • bioMerieux SA

For more information visit http://www.researchandmarkets.com/research/dn5vq5/global_next

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostic Imaging

Source:Research and Markets